跳至主要内容
临床试验/NCT05347992
NCT05347992已完成不适用

ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation)

DxTerity Diagnostics1 个研究点 分布在 1 个国家目标入组 423 人开始时间: 2022年5月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
423
试验地点
1
主要终点
Concordance between self collected samples and traditional venous draws

研究概览

简要总结

To explore the potential for use of DxTerity's AIP IFN-1 test as personalized guided care and monitoring module in patients with Systemic lupus erythematosus(SLE) using consented patient health information

详细描述

Explore and demonstrate concordance between self-collected samples and traditional phlebotomist venous draw for DxTerity AIP module and biomarkers like C3, C4, anti dsDNA and CRP in SLE participants with self-reported outcomes and medical record data.

The study will collect blood samples and self-reported information for SLE subjects, up to 5000 participants in Phase I, with a subset of 1000 continuing to Phase II with Medical records. Study participants will be recruited using a combination of digital media (including social media, advertising, bloggers, emails). Enrollment and qualification will be done along with consented retrieval of medical records using a study specific mobile app.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals aged 18 years or older.
  • Must reside in United States
  • Have a clinical diagnosis of SLE
  • Willingness to consent to provide electronic medical records (EMR)
  • Provide written informed consent and comply with the study procedures.
  • Verified diagnosis (Medical records or /and Physician Questionnaire) for SLE
  • Report one or more of the following (record all that apply):
  • Worsening or changes in symptoms or flare
  • Changes in treatment regimen
  • On standard of care treatment
  • On biologics

排除标准

  • Participants unable to complete study requirements

结局指标

主要结局

Concordance between self collected samples and traditional venous draws

时间窗: 36 months

Percentage of participants with concordant IFN-1 status as assessed by the DxTerity AIP IFN-1 module, concordance between phlebotomy draw and self-collected blood samples.

次要结局

  • Longitudinal monitoring(36 months)

研究者

发起方
DxTerity Diagnostics
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验